Medico Remedies Limited
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more
Medico Remedies Limited (MEDICO) - Total Liabilities
Latest total liabilities as of September 2025: ₹704.99 Million INR
Based on the latest financial reports, Medico Remedies Limited (MEDICO) has total liabilities worth ₹704.99 Million INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Medico Remedies Limited - Total Liabilities Trend (2013–2025)
This chart illustrates how Medico Remedies Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Medico Remedies Limited Competitors by Total Liabilities
The table below lists competitors of Medico Remedies Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ostin Technology Group Co Ltd
NASDAQ:OST
|
USA | $42.29 Million |
|
Sterling Metals Corp
OTCQB:SAGGF
|
USA | $310.10K |
|
Prajay Engineers Syndicate Limited
NSE:PRAENG
|
India | ₹3.31 Billion |
|
Visionary Copper and Gold Mines Inc.
F:CAX
|
Germany | €3.71 Million |
|
Dataprep Holdings Bhd
KLSE:8338
|
Malaysia | RM16.79 Million |
|
Aeffe S.p.A.
LSE:0GY8
|
UK | €339.85 Million |
|
IDT Australia Ltd
AU:IDT
|
Australia | AU$15.03 Million |
|
Poulaillon SA
PA:ALPOU
|
France | €51.50 Million |
Liability Composition Analysis (2013–2025)
This chart breaks down Medico Remedies Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Medico Remedies Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Medico Remedies Limited (2013–2025)
The table below shows the annual total liabilities of Medico Remedies Limited from 2013 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹573.30 Million | +30.82% |
| 2024-03-31 | ₹438.24 Million | +0.50% |
| 2023-03-31 | ₹436.05 Million | +12.18% |
| 2022-03-31 | ₹388.70 Million | -9.95% |
| 2021-03-31 | ₹431.63 Million | -4.93% |
| 2020-03-31 | ₹454.03 Million | -5.55% |
| 2019-03-31 | ₹480.74 Million | +46.93% |
| 2018-03-31 | ₹327.20 Million | +2.65% |
| 2017-03-31 | ₹318.74 Million | +3.49% |
| 2016-03-31 | ₹307.99 Million | +39.17% |
| 2015-03-31 | ₹221.30 Million | -2.37% |
| 2014-03-31 | ₹226.68 Million | +70.82% |
| 2013-03-31 | ₹132.70 Million | -- |